Yashraj Biotechnology Limited (YBL) research and innovation-driven, ISO 13485:2016, ISO 9001:2015 and OHSAS 18001:2007 certified company, established in 1999 at Navi Mumbai, Maharashtra, India.

We have operations in Germany, the USA, South Korea and we are planning to operate in other countries as well.

Our research, development and production-related activities encompass a whole range of native, recombinant and cell-derived antigens; and monoclonal antibodies. Highest standards of quality and unwavering commitment towards healthcare innovation have enabled us to capture some of the biggest market segments for various biomarker antigens and antibodies.